Differential and tumor-specific expression of CD160 in B-cell malignancies

CD160 is a human natural killer (NK)-cell–activating receptor that is also expressed on T-cell subsets. In the present study, we examined 811 consecutive cases of B-cell lymphoproliferative disorders (B-LPDs), and demonstrated CD160 expression in 98% (590 of 600) of chronic lymphocytic leukemia (CLL...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Farren, Timothy W., Giustiniani, Jerome, Liu, Feng-Ting, Tsitsikas, Dimitris A., Macey, Marion G., Cavenagh, James D., Oakervee, Heather E., Taussig, David, Newland, Adrian C., Calaminici, Maria, Bensussan, Armand, Jenner, Michael, Gribben, John G., Agrawal, Samir G.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2011
Assuntos:
Immunobiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5292591/
https://ncbi.nlm.nih.gov/pubmed/21715317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-02-334326
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados